Ho Man KAM, Derek

647-***-**** ad3vdx@r.postjobfree.com

https://www.linkedin.com/in/derek-kam-1658b794/

Experiences

MEDICAL WRITER/STATISTICIAN, BEST SOLUTION MEDICAL COMMUNICATIONS CO. LTD. (WILEY- BLACKWELL REPRESENTATIVE), HONG KONG — 12/2016-03/2023

- Biostatistical analysis and consultation for clinical research projects, including hospital- based prospective and retrospective studies, case series, physician and patient surveys, and consensus guidelines.

- Medical writing for high-impact articles in international peer-reviewed journals, international conference highlights (with travels), professional and public educational and promotional materials.

- Reviewed the efficacy, safety and cost-effectiveness of diagnostic, treatment, and management options, by synthesizing results from landmark trials and late-breaking abstracts, FDA and EMA approvals, international guidelines, health technology assessment reports, meta-analyses, and systematic reviews.

- Advised clients (pharma/biotech companies, medical associations and professors) on communication strategies, technological trends and market positioning.

- Supervised less experienced medical writers by overseeing their work outputs, providing guidance, and assigning work tasks.

- Delivered over 200 projects in 6 years, across specialties such as oncology, cardiology, endocrinology, hepatology, urology, pulmonology, hematology, HIV, psychiatry, neurology, and rare genetic disorders.

SENIOR RESEARCH ASSISTANT, THE UNIVERSITY OF HONG KONG — 05/2014-08/2015

- Digital surveillance studies to assess the epidemic preparedness of the global medical community, governments, non-government organizations and general public during the 2013 West Africa Ebola outbreaks. Duties included taking part in study design, performing data extraction and statistical analyses, and writing and submitting manuscripts for journal publication.

- Evaluated the accuracy of digital surveillance through bioinformatic analyses, including network meta-analysis and comparison with medical guideline criteria. ASSISTANT PROJECT DEVELOPMENT OFFICER, THE UNIVERSITY OF HONG KONG — 09/2015-05/2016

- Worked with school principals and teachers on the implementation of STEM (science, technology, engineering and mathematics) education across different territories of Page 1 of 5

Hong Kong. Duties included site visits, lesson plans, program progress reviews, new program proposals and website design.

RESEARCH ASSISTANT, PIONEER MEDICAL COMMUNICATIONS CO. LTD., HONG KONG — 05/2013-04/2014

- Contents and workflow design and development for a mobile health record app for monitoring everyday health, documenting personal medical history, and presenting at clinic visits.

- Coordination with IT vendor for quality assurance: ensure specifications were clearly communicated and established, to optimize coherence at all (programming, clinical and public user) levels.

RESEARCH FELLOW, CENTRE FOR GLOBAL HEALTH RESEARCH, ST. MICHAEL’S HOSPITAL, TORONTO, CANADA — 09/2006-08/2009

- National-level, large-scale Epidemiological analyses on population health trends and risk factors (e.g. 1 million households in India; nation-wide data from Brazil), using advanced regression and predictive models, standardized by United Nations data on birth, death and migration rates.

- Comprehensive causes of death analysis, looking for trends and differences over time, genders, age groups, and urbanization levels. Digitalization and re-classification of mortality data (based on new ICD coding) from provincial records in India across a 15- year period.

- Provided persuasive, quantitative evidence to inform policy decisions globally. RESEARCH COORDINATOR, CENTRE FOR RESEARCH ON INNER CITY HEALTH, ST. MICHAEL’S HOSPITAL, TORONTO, CANADA — 12/2004-11/2005

- Project coordination for qualitative inner city health care studies that focused on marginalized populations, working closely with community organizations and patient support groups.

- Surveyed pharmacists’ adaptation of guideline changes and hurdles in service delivery. Education

MA in Philosophy — University of Waterloo, Canada (2007—2008). Grade: 85.6. Selected for presentation at the Canadian Philosophical Association annual meeting. MPhil in Epidemiology — Cambridge University, UK (2003—2004). Grade (UK System): 74.25 (75 for Distinction)

MSc in Bioengineering — Imperial College London, UK (2002—2003). Grade (UK System): 62.8

Page 2 of 5

BSc (4-year Honours) Life Sciences (Research Stream) — Queen’s University, Canada

(1999—2002). Grade: 82.5

Certified Associate in Project Management (CAPM) — Project Management Institute (2007) PhD in Philosophy (Incomplete, due to financial constraint; 2009—2013) — The University of Hong Kong

Computing Skills

Statistical analyses: Stata (expert-level: capable of customized, iterative programming, complex graph designs, survival analysis, regressions and predictive models, etc.); Python

(fluent in Pandas, spaCy, NLTK, scikit-learn and Scrapy libraries); Power BI (SQL-based transformations); SAS (biostatistics); SPSS; UCINET (network analysis) Data (competent): Microsoft Access, Excel

Presentation and publishing: Microsoft Office suite, Endnote (referencing), Adobe Illustrator and Photoshop (graphic designs), Corel VideoStudio (video-editing), Wordpress

(building websites)

Clinical Experiences

Pharmacy Assistant, Primary Care Clinic, Central, Hong Kong (2014; 4 months) — Dispensed medications to patients, scheduled clinical appointments, and maintained clinical database (while working as Research Assistant to understand clinical workflow). Volunteer, Emergency Department, York Central Hospital, Ontario Canada (2005; 6 months) — Helped with triage of patients (making brief notes of their conditions) and fulfilling patient needs in the emergency room (e.g. answering questions, delivering blankets and wheelchairs); filed medical records.

Lab Work

MSc thesis project (electrochemistry) — Department of Bioengineering, Imperial College London, London (2003, 4 months)

4th year undergraduate research projects (cancer genetics and proteomics) and additional volunteering work — Department of Biochemistry, Queen’s University, Kingston, Canada

(2001-2, 1 year)

Character

- Detailed, action-driven, caring and innovative.

- Attending to needs in detail, for finding innovative solutions. Page 3 of 5

- Highly motivated to help patients by improving real-life outcomes.

- Empathetic about others’ well-being and persistent in building relationships.

- Strong interests in new analytic methods (e.g. natural language processing and machine learning models).

Hobbies

- Leadership training courses, including on team-building, community projects, life goals, action plans, and interpersonal relationships.

- Sports such as hiking, running, swimming, skating, snorkeling. Selected High-Impact Publications

Hossain L, Kam D. Meta-analysis of the accuracy of syndromic surveillance. 2022; arXiv:2206.09430.

Hossain L, Kong F, Kam D. Digital surveillance networks of 2014 Ebola epidemics and lessons for COVID-19. 2022; arXiv:2206.09229.

Hossain L, Kam D, Kong F, Wigand RT, Bossomaier T. Social media in Ebola outbreak. Epidemiol Infect. 2016;144(10):2136-43. doi: 10.1017/S095026881600039X. Jha P, Kumar R, Khera A, Bhattacharya M, Arora P, Gajalakshmi V, Bhatia P, Kam D, Bassani DG, Sullivan A, Suraweera W, McLaughlin C, Dhingra N, Nagelkerke N; Million Death Study Collaborators. HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes. BMJ. 2010;340:c621. doi: 10.1136/bmj.c621. Park-Wyllie LY, Kam D, Bayoumi AM. The adherence support gap: the 'ideal' versus 'reality' of antiretroviral adherence support provided by HIV health providers in clinical practice. Ann Pharmacother. 2009;43(6):1036-44. doi: 10.1345/aph.1L663. Ramin B, Kam D, Feleke B, Jacob B, Jha P. Smoking, HIV and non-fatal tuberculosis in an urban African population. Int J Tuberc Lung Dis. 2008;12(6):695-7. Park-Wyllie LY, Levine MA, Holbrook A, Thabane L, Antoniou T, Yoong D, Kam D, Bayoumi AM. Outcomes of dosage adjustments used to manage antiretroviral drug interactions. Clin Infect Dis. 2007;45(7):933-6. doi: 10.1086/521252. AS MEDICAL WRITER AND/OR BIOSTATISTICIAN (ACKNOWLEDGED AS SERVICE PROVIDER): LAM BHW et al. A territory-wide real-world efficacy and toxicity analysis of abiraterone acetate versus docetaxel in 574 Asian patients with metastatic hormone-sensitive prostate cancer. Clin Genitourin Cancer. 2023.

Page 4 of 5

Tam CC, Tse HF. Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery Disease. J Clin Med. 2022;11(24):7440. doi: 10.3390/jcm11247440.

Chiu PKF, Lee EKC, Chan MTY, Chan WHC, Cheung MH, Lam MHC, Ma ESK, Poon DMC. Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro- Oncology. Front Oncol. 2022;12:962958. doi: 10.3389/fonc.2022.962958. Ngu SF, Tse KY, Chu MMY, Ngan HYS, Chan KKL. Olaparib dose re-escalation in ovarian cancer patients who experienced severe and/or uncommon adverse events: A case series. Asia Pac J Clin Oncol. 2021;17 Suppl 3:3-11.

Kwong A, Cheng KD, Hsue CV, Hui SK, Leung CR, Leung KA, Ngan KR, Soong SI. BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists. Asia Pac J Clin Oncol. 2019;15 Suppl 2:20-31. doi: 10.1111/ajco.13116.

REFERENCES AND MANUSCRIPTS AVAILABLE UPON REQUEST. This resume was last updated on February 21, 2024. Page 5 of 5

Contact this candidate